Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 3, 2004, Pages 1045-1050

  Mulatero, Paolo ^a,g   Stowasser, Michael ^b   Loh, Keh Chuan ^c   Fardella, Carlos E ^d   Gordon, Richard D ^b   Mosso, Lorena ^d   Gomez Sanchez, Celso E ^e   Veglio, Franco ^a   Young Jr , William F ^f  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c TAN TOCK SENG HOSPITAL   (Singapore)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^e UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^f MAYO CLINIC   (United States)

^g Ospedale San Vito   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE;

ADENOMA; ADRENAL GLAND; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; EVALUATION; HEALTH CENTER; HUMAN; HYPERTENSION; HYPOKALEMIA; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; SURGICAL TECHNIQUE; VENOUS BLOOD;

ALDOSTERONE; CHILE; FOLLOW-UP STUDIES; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; ITALY; MASS SCREENING; MINNESOTA; QUEENSLAND; RENIN; RETROSPECTIVE STUDIES; SINGAPORE;

EID: 1642390149     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031337     Document Type: Article

References (36)

1. Kaplan NM 1994 Clinical hypertension. 6th ed. Baltimore: Williams & Wilkins;389-408
2. Ganguly A 1998 Primary aldosteronism. N Engl J Med 339:1828-1834
3. Gordon RD, Ziesak MD, Tunny TJ, Stowasser M, Klemm SA 1993 Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers. Clin Exp Pharmacol Physiol 20:296-298
4. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC 1994 High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21:315-318
5. Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young Jr WF 2000 Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 85:2854-2859
6. Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montera J 2000 Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 85:1863-1867
7. Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, Veglio F 2002 Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 40:897-902
8. Kaplan NM 2001 Cautions over the current epidemic of primary aldosteronism. Lancet 357:953-954
9. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM 1999 Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 353:40
10. Holland OB, Brown H, Kuhnert L, Fairchild C, Risk M, Gomez-Sanchez CE 1984 Further evaluation of saline infusion for the diagnosis of primary aldosteronism. Hypertension 6:717-723
11. Young Jr WF, Stanson AW, Grant CS, Thompson GB, van Heerden JA 1996 Primary aldosteronism: adrenal venous sampling. Surgery 120:913-919
12. Mulatero P, Veglio F, Pilon C, Rabbia F, Zocchi C, Limone P, Boscaro M, Sonino N, Fallo F 1998 Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. J Clin Endocrinol Metab 83: 2573-2575
13. Jonsson JR, Klemm SA, Tunny TJ, Stowasser M, Gordon RD 1995 A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem Biophys Res Commun 207:565-571
14. Mulatero P, Curnow KM, Aupetit-Faisant B, Foekling M, Gomez-Sanchez C, Veglio F, Jeunemaitre X, Corvol P, Pascoe L 1998 Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. J Clin Endocrinol Metab 83:3996-4001
15. Young Jr WF 2002 Primary aldosteronism: management issues. Ann NY Acad Sci 970:61-76
16. Sawka AM, Young WF, Thompson GB, Grant CS, Parley DR, Leibson C, van Heerden JA 2001 Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 135:258-261
17. Rocha R, Martin-Berger CL, Yang P, Scherrer R, Delyani J, McMahon E 2002 Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Endocrinology 143:4828-4836
18. Delcayre C, Swynghedauw B 2002 Molecular mechanisms of myocardial remodeling. The role of aldosterone. J Mol Cell Cardiol 34:1577-1584
19. Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, McMahon EG, Delyani JA 2002 Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol 283: H1802-H1810
20. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT 2002 Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol 161:1773-1781
21. Young M, Head G, Funder J 1995 Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol 269:E657-E662
22. Rocha R, Funder JW 2002 The pathophysiology of aldosterone in the cardiovascular system. Ann NY Acad Sci 970:89-100
23. Rossi GP, Sacchetto A, Pavan E, Palatini P, Graniero GR, Canali C, Pessina AC 1997 Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 95:1471-1478
24. Schmidt BM, Schmieder RE 2003 Aldosterone-induced cardiac damage: focus on blood pressure independent effects. Am J Hypertens 16:80-86
25. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709-717
26. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M 2003 Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309-1321
27. Laragh J 2001 Abstract, closing summary, and table of contents for Laragh's 25 lessons in pathophysiology and 12 clinical pearls for treating hypertension. Am J Hypertens 14:1173-1177
28. Sywak M, Pasieka JL 2002 Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg 89:1587-1593
29. Blumenfeld JD, Laragh JH 1998 Renin system analysis: a rational method for the diagnosis and treatment of the individual patient with hypertension. Am J Hypertens 11:894-896
30. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group 2002 Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981-2997
31. Gordon RD, Gomez-Sanchez CE, Hamlet SM, Tunny TJ, Klemm SA 1987 Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension. J Hypertens Suppl 5:S103-S106
32. Magill SB, Raff H, Shaker JL, Brickner RC, Knechtges TE, Kehoe ME, Findling JW 2001 Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 86:1066-1071
33. Young Jr WF 1999 Primary aldosteronism: a common and curable form of hypertension. Cardiol Rev 7:207-214
34. Stowasser M, Gordon RD, Rutherford JC, Nikwan NZ, Daunt N, Slater GJ 2001 Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 2:156-169
35. Blumenfeld JD, Vaughan Jr ED 1999 Diagnosis and treatment of primary aldosteronism. World J Urol 17:15-21
36. Celen O, O'Brien MJ, Melby JC, Beazley RM 1996 Factors influencing outcome of surgery for primary aldosteronism. Arch Surg 131:646-650